LH

Labcorp Holdings Inc.

$370.88

-0.26%
SectorHealthcareIndustryDiagnostics & ResearchCountryUnited States

Labcorp Holdings Inc. provides laboratory services. It operates in Diagnostics Laboratories and Biopharma Laboratory Services segments. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing service, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations.

Source: Yahoo Finance
AI summary

Price & performance

1M+15.3%
3M+15.2%
YTD+42.3%
1Y+41.4%
52-week range—
Beta0.53
Full chart and returns against a benchmark

Q-Score

76/ 100

Quality against peers; 50 is the peer median.

Growth55
Risk92
Performance65
Valuation66
Profitability62
Leverage56
Sentiment30
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$14B+7.2%
Net income$876.5M+17.5%
Net margin6.3%+0.5 pts
Historical fundamentals

Revenue exposure

Regions, segments, customers and suppliers

Valuation

LHIndustryP/E30.0041.31P/S2.065.66EV/EBITDA16.1531.63P/B3.404.91PEG1.723.59
Dividend yield0.79%
Every valuation metric

Earnings

Oct 28next report, before the open
EPS estimate$4.65
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate